CRSP logo

CRISPR Therapeutics AG (CRSP) P/E Ratio

PE Ratio:

N/A
October 31, 2025

Summary

  • CRSP price to earnings ratio is not available.

Performance

CRSP PE Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

OtherCRSPvaluation metrics

PE Ratio Formula

P/E =  
Price
TTM Earnings Per Share

CRSP PE Ratio Trends

PeriodPeriodPE RatioPE RatioPricePriceTTM EPSTTM EPSTTM RevenueTTM Revenue
1D1 Day-+4.7%-20.1%+1.0%
1M1 Month--5.5%--
3M3 Months-+14.1%-20.1%+1.0%
6M6 Months-+67.3%--
YTDYTD-+62.6%--
1Y1 Year-+26.1%-68.0%-81.2%
5Y5 Years--26.3%-66.7%-50.8%

CRSP PE Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month
3M3-Month
6M6-Month
1Y1-Year
3Y3-Year
5Y5-Year31.6912.00
All-TimeAll-Time215.3212.00

CRSP PE Ratio History

DateValue
2021
17.15(-72.6%)
DateValue
2019
62.70

FAQ

  • What is the all-time high PE ratio for CRISPR Therapeutics AG?

What is the all-time high PE ratio for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high price to earnings ratio is 215.32
On this page